Eflornithine hydrochloride Monohydrate
CAS No. 96020-91-6
Eflornithine hydrochloride Monohydrate( DFMO | Eflornithine )
Catalog No. M16851 CAS No. 96020-91-6
Eflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | 112 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEflornithine hydrochloride Monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.
-
DescriptionEflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.(In Vivo):Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension.
-
In Vitro——
-
In VivoEflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension.
-
SynonymsDFMO | Eflornithine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number96020-91-6
-
Formula Weight236.64
-
Molecular FormulaC6H15ClF2N2O3
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO.Cl.NCCCC(N)(C(F)F)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mohammed A, et al. Y Prev Res (Phila). 2014 Dec;7(12):1198-209.
molnova catalog
related products
-
Norwogonin-8-O-glucu...
The roots of Glychirriza glabra L.
-
Sulforhodamine B sod...
Sulforhodamine B sodium salt is a fluorescent dye. It can be used from laser-induced fluorescence to the quantification of cellular proteins of cultured cells.
-
Bryonolic acid
Bryonolic acid is a triterpenoid found in the Cucurbitaceae family of plants. Bryonolic acid has anti-inflammatory and antioxidant activities. It has been found to exhibit antineoplastic activity.
Cart
sales@molnova.com